As longstanding members of AAPS (America Association of Pharmaceutical Scientists), we are delighted to be attending the 2025 AAPS National Biotechnology Conference, May 4-7 in Boston!
A key event for leaders across biotech and pharma, we look forward to networking and knowledge-sharing around the topics of gene editing, personalized medicine, and sustainable biomanufacturing, and of course developing and characterizing complex biologics with regulatory-compliant bioassays.
Will you be attending? Be sure to visit the Custom Biologics team at our booth, #406! Read on for the event summary, then book a meeting with us during the event.

Track 1: Inspiring Innovation in Formulation, Bioprocessing, and Drug Delivery
Explore the forefront of formulating and delivering biologics for both new and established modalities, including multi-specific antibodies, ADCs, peptides, vaccines, nanomedicines, cell and gene therapies. This track delves into leveraging prior knowledge with cutting-edge technologies to accelerate product development, enhance bioprocessing, improve quality control through PAT, and spotlight patient-centric technologies and AI integration.
- Theme 1: Accelerating Novel Formulation Development of Biologics for Newer and Established Modalities
- Theme 2: Bioprocessing, Characterization & Comparability for Complex Biologics
- Theme 3: Patient-Centric Product Design and Precision Medicine
Track 2: From Bench to Bedside: Bioanalysis and Translational Science
This track concentrates on innovative bioanalytical techniques to evaluate newer modalities, with a special focus on translational science for clinical outcomes prediction.
- Theme 1: Breaking Barriers: Bioanalytical Innovation for Complex Biologics
- Theme 2: Managing Global Clinical Trials and Crises in Sample Logistics
- Theme 3: Preclinical and Clinical PK/PD, Safety Translation of Newer Modalities
Let's Connect at AAPS 2025 in Boston!
If you'll be attending, be sure to schedule time to meet with our science team (booth #406) to discuss your bioanalytical challenges and goals at every stage of drug development, including:
- Cell therapies
- Gene therapies/genetic medicines
- Vaccines
- Biologics
- Biosimilars
- Immunotherapies
- All other pharmaceutical, biotech, and biopharmaceutical products
As a reminder, Custom Biologics is your regulatory compliant bioanalytical CRO and laboratory that can assist you with:
- Cell-based potency assays
- ELISA
- Immunogenicity (ADA/Nab) assays
- AAV Characterization/Transgene Expression
- Biomarker quantification
- PK/TK Studies
Schedule a meeting with our team. We hope to see you there!
Where: Boston
When: May 4-7, 2025
Booth: 406
Registration & Agenda: Full Program